XML 47 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2014
Fair Value of Financial Instruments  
Schedule of fair value of the financial assets and liabilities

 

In accordance with the fair value hierarchy described above, the following tables show the fair value of the Company’s financial assets and liabilities that are required to be measured at fair value, in thousands:

 

 

 

 

 

Fair Value Measurements at

 

 

 

 

 

September 30, 2014

 

 

 

 

 

(unaudited)

 

 

 

 

 

 

 

Significant

 

 

 

 

 

Total Carrying

 

Quoted Prices

 

Other

 

Significant

 

 

 

Value at

 

in Active

 

Observable

 

Unobservable

 

 

 

September 30,

 

Markets

 

Inputs

 

Inputs

 

 

 

2014

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

37,780 

 

37,780 

 

 

 

Marketable securities

 

34,783 

 

 

34,783 

 

 

Long term marketable securities

 

15,763 

 

 

15,763 

 

 

Marketable securities - restricted (SERP)

 

305 

 

 

305 

 

 

Total assets at fair value

 

$

88,631 

 

$

37,780 

 

$

50,851 

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

Derivative liabilities

 

$

7,258 

 

$

 

$

 

$

7,258 

 

 

 

 

 

 

Fair Value Measurements at

 

 

 

 

 

December 31, 2013

 

 

 

 

 

 

 

Significant

 

 

 

 

 

Total Carrying

 

Quoted Prices

 

Other

 

Significant

 

 

 

Value at

 

in Active

 

Observable

 

Unobservable

 

 

 

December 31,

 

Markets

 

Inputs

 

Inputs

 

 

 

2013

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

 

32,980 

 

$

32,980 

 

$

 

$

 

Marketable securities

 

49,211 

 

 

49,211 

 

 

Long term marketable securities

 

8,756 

 

 

8,756 

 

 

Marketable securities - restricted (SERP)

 

305 

 

 

305 

 

 

Total assets at fair value

 

$

 

91,252 

 

$

 

32,980 

 

$

58,272 

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

Derivative liabilities

 

$

 

12,644 

 

$

 

 

$

 

 

$

12,644 

 

 

Schedule of Level 3 liabilities included in Non-current Liabilities on the Balance Sheet

The following table presents information about the Company’s Level 3 liabilities as of December 31, 2013 and September 30, 2014 that are included in the Non-Current Liabilities section of the Consolidated Balance Sheets, in thousands:

                                                                                                                                                                                                              

 

 

Nine Months ended

 

 

 

September 30, 2014

 

 

 

(unaudited)

 

 

 

 

 

Balance at December 31, 2013

 

$

12,644

 

Changes in fair value of derivative liabilities included in earnings

 

(2,115

)

Reduction due to conversion of debt to equity

 

(3,271

)

Balance at September 30, 2014

 

$

7,258

 

 

Schedule of unrestricted marketable securities

 

Unrestricted marketable securities held by the Company were as follows, in thousands:

 

At September 30, 2014, unaudited:

                                                                                                                                                                                                              

Available for Sale

 

Amortized
Cost

 

Gross
Unrealized
Gains

 

Gross
Unrealized
Losses

 

Fair Value

 

Corporate debt securities

 

$

50,581

 

$

14

 

$

(49

)

$

50,546

 

 

At December 31, 2013:

                                                                                                                                                                                                              

Available for Sale

 

Amortized
Cost

 

Gross
Unrealized
Gains

 

Gross
Unrealized
Losses

 

Fair Value

 

Corporate debt securities

 

$

57,967

 

$

33

 

$

(33

)

$

57,967

 

 

Schedule of contractual maturities of the unrestricted available for sale marketable securities held

 

The contractual maturities of the unrestricted available for sale marketable securities held by the Company were as follows, in thousands:

                                                                                                                                                                                                              

 

 

September 30,
2014

 

 

 

(unaudited)

 

 

 

 

 

Less Than 1 Year

 

$

34,783 

 

1 - 5 Years

 

15,763 

 

Greater Than 5 Years

 

 

Total

 

$

50,546 

 

 

Warrant to Purchase Common Stock
 
Fair value of financial instruments  
Schedule of assumptions used to calculate fair value of liabilities

 

                                                                                                                                                                                                             

Exercise Price

 

$4 - $5 per share

 

Volatility

 

50%

 

Stock Price as of September 30, 2014

 

$8.69 per share

 

Term

 

6.3 - 7.2 years

 

Dividend Yield

 

0.0%

 

Risk-Free Rate

 

2.03% - 2.18%

 

 

Interest Make Whole Liability
 
Fair value of financial instruments  
Schedule of assumptions used to calculate fair value of liabilities

 

                                                                                                                                                                                                              

Volatility

 

45%

 

Stock Price as of September 30, 2014

 

$8.69 per share

 

Credit Spread

 

1254 bps

 

Term

 

2.6 years

 

Dividend Yield

 

0.0%